hex-clinical-trial

Status

GENETIC-AF is currently enrolling patients in U.S., Canada and Europe

175 Patients enrolled as of March 6, 2017

Phase 2B interim efficacy analysis outcome anticipated in third quarter of 2017 (Guidance as of March 21, 2017)